aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) was the recipient of a large decrease in short interest in the month of April. As of April 30th, there was short interest totalling 299,200 shares, a decrease of 25.1% from the April 15th total of 399,500 shares. Based on an average trading volume of 560,900 shares, the […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 299,200 shares, a decrease of 25.1% from the April 15th total of 399,500 shares. Based on an average trading volume of 560,900 shares, the short-interest ratio is […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) was the recipient of a large decline in short interest in the month of April. As of April 30th, there was short interest totalling 299,200 shares, a decline of 25.1% from the April 15th total of 399,500 shares. Based on an average daily volume of 560,900 shares, the […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) – Research analysts at HC Wainwright upped their FY2026 EPS estimates for shares of aTyr Pharma in a report issued on Wednesday, May 10th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of $0.68 per share for the year, up from their […]